Navigation Links
Patient Safety Technologies Reports Second Quarter 2013 Results

IRVINE, Calif., Aug. 12, 2013 /PRNewswire/ -- Patient Safety Technologies, Inc. (the "Company", OTCBB: PSTX, OTCQB: PSTX) today announced results for its second quarter ended June 30, 2013.

Expanded Customer Base and Financial Highlights
During the second quarter of 2013 the Company grew its installed customer base of facilities using its SurgiCount Safety-Sponge® System to 294. This compares to 215 facilities as of the end of the second quarter of 2012 and represents year over year growth in the Company's installed customer base of 37%. Additionally, as of the date of this release the Company has implemented or signed contracts and scheduled implementations for additional facilities, collectively growing the number of facilities currently installed and those with signed agreements and scheduled implementations to 320.  Although not necessarily proportional to reported revenues, the number of facilities using the Company's products is a good indicator of our underlying business.

Total revenue for the second quarter of 2013 was $5.0 million. This compares to total revenue of $4.4 million for the second quarter of 2012. The higher revenue for the second quarter of 2013 as compared to the same period in 2012 was primarily related to the larger customer installed base during the second quarter of 2013, partially offset by a number of factors including the impact of a number of our larger existing customers switching the distributors they choose to fulfill our products.  We believe the effects of such distributor switchings are temporary, as the existing distributor typically discontinues ordering our products in advance of when the newly selected distributor begins initiating orders to build up its inventory to fulfill our products for the end user facilities, however our end user facility customers will continue their consume our products at their normal consumption levels.Reported GAAP gross margins were 43% for the second quarter of 2013 as compared to 42% for the same period in 2012 and 39% during the first quarter of 2013. Because the Company's reported GAAP cost of revenues includes certain non-cash depreciation expense, there can be a significant difference between reported gross margins and the actual cash gross margins realized by the Company.  Excluding the non-cash depreciation expense that is included in reported cost of revenues, our non-GAAP Cash Gross Margins were 53% for the second quarter of 2013 as compared to 51% for the same period in 2012, and 50% during the first quarter of 2013. The expansion of both our reported GAAP and non-GAAP Cash Gross Margins was the result of a number of factors, including the benefit of cost reductions we achieved on our sponge products totaling approximately 10% that became effective during the first quarter of 2013. Given the first in, first out inventory methodology we employ with our sponge products, we realized a portion of the benefits from these cost reductions during the second quarter of 2013, however we expect to realize increased benefits from this cost reduction during the third quarter of 2013 and the full benefits by the end of 2013.

Reported operating expenses for the second quarter of 2013 were $2.5 million, an increase of $92 thousand, or 4%, as compared to $2.4 million during the same period in 2012. The primary reasons for the relatively minimal increase in operating expenses during the second quarter of 2013 as compared to the same period in 2012, despite the large growth in our customer installed base and reported revenues, were lower one-time implementation expenses offset by higher employment related expenses.

During the second quarter of 2013 the Company generated a GAAP Operating Loss of $353 thousand and Adjusted Operating Income (as defined below) of $509 thousand. This compares with a GAAP Operating Loss of $524 thousand and Adjusted Operating Income of $177 thousand during the second quarter of 2012. The primary reasons for the lower reported GAAP Operating Loss and the increase in Adjusted Operating Income reported during the second quarter of 2013 as compared to the same period in 2012, was the higher reported revenue from a larger installed customer base, expanding gross margins and minimally higher operating expenses. 

"During the second quarter we continued to add to our world class customer base, grow our reported revenues and expand our gross margins. Additionally, despite making additional investments in our business we continued to grow our adjusted operating income, reflecting the breakeven point we have surpassed with our existing market penetration and the operating leverage in our business model," stated Brian E. Stewart, President and Chief Executive Officer of Patient Safety Technologies, Inc.

"Subsequent to the end of the second quarter, U.S. News and World Report released its 2013-14 Best Hospitals Honor Roll.  Once again our SurgiCount Safety-Sponge® System has established itself as the retained sponge solution of choice among this elite group of healthcare providers, being used at more facilities on this list than all competing solutions combined.  We congratulate all our customers who received this honor and are proud to have helped enable them to improve their patient outcomes.  We believe our continued dominant share within this group further improves our position to become the clinical standard of care for this preventable Never Event," continued Mr. Stewart.The Company's first quarter of 2013 financial statements are included in its Quarterly Report on Form 10-Q filed by the Company on August 12, 2013 and available at the SEC's website at Reconciliation of GAAP to Non-GAAP Results (Unaudited) For the ThreeFor the SixMonths Ended Months EndedJune 30,June 30,in thousands2013201220132012Reported Revenue$






7,505.7Reported Operating Loss$







Stock based compensation215.1197.7404.9397.4Plus:

Depreciation and amortization646.6503.31,283.4870.4Adjusted Operating Income/(Loss)$






(558.0)Reported Revenue$






7,505.7Reported Gross profit2,118.41,855.23,957.23,091.9Reported Gross margin43%42%41%41%Plus:

Depreciation recorded in cost of revenue528.1392.91,047.8650.4Cash Gross profit$






3,742.3Cash Gross margin53%51%52%50%To supplement the Company's presentation of operating income and (loss) measured in accordance with GAAP, we also use a non-GAAP measure of operating income, herein defined as Adjusted Operating Income (in the event this amount is negative it is herein defined as Adjusted Operating Loss). Reconciliation of GAAP operating loss to Adjusted Operating Income or Loss for the second quarters of 2013 and 2012 are shown above. How we define Adjusted Operating Income or Loss herein may not be consistent with how we have defined this non-GAAP measure historically.  Additionally, the Company also includes a non-GAAP measure of gross profit and gross margins, herein defined as Cash Gross Profit and Cash Gross Margin, which excludes from these calculations the effects of non-cash depreciation expense. Non-GAAP measures are provided to enhance investors' overall understanding of the Company's current financial performance, prospects for the future and as a means to evaluate period-to-period comparisons. The Company believes that the use of non-GAAP operating income, gross profit and gross margins provides meaningful supplemental information regarding financial performance by excluding certain expenses and benefits that may not be indicative of recurring core business operating results. The Company believes these non-GAAP measures when viewed with GAAP results and the accompanying reconciliation, enhances the comparability of results against prior periods and allows for greater transparency of financial results. The Company believes these non-GAAP measure facilitate management's internal comparison of the Company's financial performance to that of prior periods as well as trend analysis for budgeting and planning purposes. The presentation of these non-GAAP measure is not intended to be considered in isolation or as a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP.

Surgical Adverse Events and Retained Surgical Sponges
Surgical never events are costly to the health care system and are associated with serious harm to patients1.  Retained foreign bodies are estimated to represent up to 49.8% of all reported surgical never events1 with surgical sponges representing the vast majority of items unintentionally retained2.  Estimated to occur as often as 1 in every 1,000 to 1,500 abdominal operations to 1 in every 8,000 in patient operations2, with an estimated 32 million surgical procedures annually in the U.S. this implies approximately 4,000 retained sponge incidents each year, 11 every day.  The negative impact to patient outcomes from retained foreign objects varies and can be significant, with permanent injuries in an estimated 16% of incidents and patient mortality in 5%1. Cost ramifications can be considerable and include legal expenses and awards, non-reimbursable healthcare services, loss of time, loss of reputation for involved individuals and facilities and the negative impact on pay for performance metrics. 

About Patient Safety Technologies, Inc. and SurgiCount Medical
Patient Safety Technologies, Inc., through its wholly-owned operating subsidiary SurgiCount Medical, Inc., provides the Safety-Sponge® System, a solution clinically proven to improve patient safety and reduce healthcare costs by helping eliminate retained surgical sponges.  The market leading retained sponge prevention solution, the Safety-Sponge® System is used in more than 315 government, teaching and community hospitals across the U.S., including 6 of the 2013-14 U.S. News and World Report Best Hospital Honor Roll recipients, representing more total users and more Honor Roll users than all retained sponge prevention solutions combined.  For more information, contact SurgiCount Medical, Inc. at (949) 387-2277 or visit

Forward Looking Statements

Statements in this press release regarding our business that are not historical facts are "forward-looking statements" (within the meaning of Section 21E of the Securities Exchange Act of 1934) that involve risks and uncertainties. Forward-looking statements reflect our management's current views with respect to future events and financial performance; however, you should not put undue reliance on these statements.  When used, the words "anticipates," "believes," "expects," "intends," "future," and other similar expressions, without limitation, identify forward-looking statements.  Forward-looking statements are not guarantees of future performance and are inherently subject to uncertainties and other factors which could cause actual results to differ materially from the forward-looking statements. These factors and uncertainties include but are not limited to: our ability to implement in all hospitals within the larger hospitals organizations with which we have agreements, our ability to implement in those hospitals with which we have scheduled implementations, the early stage of adoption of our Safety-Sponge® System and the need to expand adoption of our Safety-Sponge® System; the impact on our future revenue and cash flows from the ordering patterns of our exclusive distributor Cardinal Health; our need for additional financing to support our business; our reliance on third-party manufacturers, some of whom are sole-source suppliers, and on our exclusive distributor; and any inability to successfully protect our intellectual property portfolio.  In light of the risks and uncertainties, there can be no assurance that any forward-looking statement will in fact prove to be correct.

Forward-looking statements can be affected by many other factors, including, those described in the "Business", "Management's Discussion and Analysis of Financial Condition and Results of Operations" and "Factors Affecting Future Results" sections of our Annual Report on Form 10-K for 2012, our Quarterly Reports on Form 10-Q and in our other public filings. These documents are available online through the SEC's website, Forward-looking statements are based on information presently available to senior management, and we have not assumed any duty to update any forward-looking statements.PATIENT SAFETY TECHNOLOGIES, INC.Condensed Consolidated Statements of Operations
(Unaudited)Three Months EndedSix Months EndedJune 30,June 30,2013201220132012Revenues$




7,505,734Cost of revenue2,837,1112,548,2475,756,0284,413,878Gross profit2,118,4251,855,2293,957,2423,091,856Operating expenses:Research and development160,958141,842294,369289,484Sales and marketing921,7911,084,5111,989,7202,383,607General and administrative1,388,1531,152,7042,638,7102,244,570Total operating expenses2,470,9022,379,0574,922,7994,917,661Operating loss(352,477)(523,828)(965,557)(1,825,805)Other income (expense)Interest income (expense),net1,371(795)3,4933,083Interest expense related party(75,103)-(143,819)-Total other (expense) income(73,732)(795)(140,326)3,083Loss before income taxes(426,209)(524,623)(1,105,883)(1,822,722)Income tax  provision---(3,712)Net loss (426,209)(524,623)(1,105,883)(1,826,434)Preferred dividends(142,406)(132,369)(284,813)(262,891)Net loss applicable to common shareholders$




(2,089,325)Loss per common shareBasic and Diluted$




(0.06)Weighted average common shares
outstanding:Basic and Diluted37,597,10835,260,24337,443,28434,641,399 PATIENT SAFETY TECHNOLOGIES, INC.Condensed Consolidated Balance SheetsJune 30,2013December 31,2012(Unaudited)AssetsCurrent assets:Cash and cash equivalents$


5,177,082Accounts receivable1,834,0131,415,634Inventories, net2,695,8803,968,436Prepaid expenses191,435308,285Total current assets9,717,55210,869,437Property and equipment, net4,413,3544,833,754Goodwill1,832,0271,832,027Patents, net1,976,7322,139,202Other assets37,46237,462Total assets$


19,711,882Liabilities and Stockholders' EquityCurrent liabilitiesAccounts payable$


4,499,002Accrued liabilities365,953960,062Deferred revenue-current portion805,715846,395Total current liabilities5,471,5513,928,468Deferred revenue615,446846,395Total liabilities6,086,9977,274,854Stockholders' equity Total stockholders' equity11,890,13012,437,028Total liabilities and stockholders' equity$



[1] Mehtsun, et al. Surgical never events in the United States, J Surg 2012;10.005

[2] Cima RR, Kollengode A, Garnatz J, et al. Incidence and characteristics of potential and actual retained foreign object events in surgical patients. J Am Coll Surg 2008;207:80-87

SOURCE Patient Safety Technologies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Study Showed Patients Treated With The miraDry© System Experienced 82 Percent Sweat Reduction On Average
2. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
3. Watching, Reading and Listening: A New Way to Interact with Patient Information
4. Phreesia identifies over 26% of patients who require additional autism evaluation
5. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
6. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
7. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
8. New post-hoc analyses examined Neupro® effects on pain, depressed mood, apathy and fatigue in patients with Parkinsons disease
9. Patient Advocate Foundation Announces New Co-Pay Relief (CPR) Offerings for Patients Facing Health Issues Due to Electrolyte Imbalance
10. Quest Diagnostics Establishes Unique Healthcare Identifier to Improve Access to Vital Patient Health Information; 80 Million Patient IDs Created to Date
11. Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way
Post Your Comments:
(Date:10/13/2015)... 2015  SRI International has been awarded a ... five years by the National Institute of Allergy ... Institutes of Health, for the development of products ... of radiation exposure. Under this multi-year contract, ... will provide services, facilities, expertise and capabilities to ...
(Date:10/13/2015)... 2015 ) ... & European markets for Meniscal Repair - 16 ... --> ) has announced the addition ... Meniscal Repair - 16 Countries (2010-2021)" report ... Markets ( ) has announced the addition ...
(Date:10/13/2015)... 2015  Graduate students across the country, with ... will soon have the opportunity to learn about ... drug discovery and development process. Eli Lilly and ... 10 leaders from academic institutions to create an ... of Drug Development."  Lilly will formally unveil the ...
Breaking Medicine Technology:
(Date:10/13/2015)... ... ... The American Institutes for Research ( AIR ) developed a collection of ... experienced sexual assault and other trauma. The toolkit, funded by the U.S. Department of ... Act's 21st anniversary. , AIR developed the Safe Place toolkit ...
(Date:10/13/2015)... ... , ... Vision Group Holdings, the largest LASIK provider in North America, announced ... LASIK Vision Institute and TLC Laser Eye Centers, Vision Group Holdings has performed more ... , Global Laser Vision will continue to operate in San Diego as it has ...
(Date:10/13/2015)... ... October 13, 2015 , ... Sir Grout of Greater ... the local Boston chapter of Ronald McDonald House Charities® (RMHC®). This donation was made ... Sir Grout of Greater Boston since its inception. , “We believe strongly in the ...
(Date:10/13/2015)... ... October 13, 2015 , ... CURE Media ... today announced a new partnership with the International Waldenstrom’s Macroglobulinemia Foundation (IWMF) ... non-Hodgkin’s lymphoma, their families and physicians. , “Waldenstrom’s Macroglobulinemia is a so-called ...
(Date:10/13/2015)... ... October 13, 2015 , ... "My friend's son suffers from ... his infected cheeks," said an inventor from Platteville, Colo. "I came up with this ... He developed the UNTOUCHABLE to prevent a child from rubbing or scratching his or ...
Breaking Medicine News(10 mins):